Order No. 2501 on pharmacies' production of cannabis end products. País/Territorio Dinamarca Tipo de documento Reglamento Fecha 2021 Fuente FAO, FAOLEX Materia Cultivos, General Palabra clave Protección del consumidor Plantas oleaginosas Cultivos prohibidos Envasado/etiquetado Procesamiento/manipulación Salud pública Inspección Área geográphica Europa, Europa y Central Asia, Países de la Unión Europea, Mar del Norte, Atlántico Nordeste, Europa Septentrional Entry into force notes This Order enters into force on 1 January 2022. Resumen The present Order, adopted by the Ministry of Health, lays down rules on pharmacies' production of cannabis end products, as defined in Article 3 of Act No. 1668 on a pilot scheme for medicinal cannabis. Only pharmacies and pharmacy branches are authorized to produce cannabis end products. The Order prohibits the production of such products by pharmacy outlets. Pharmacies are required to ensure the quality of their production of cannabis end products through documenting its quality assurance, including describing responsibilities, document handling, procedures, and risk management measures related to the production of cannabis finished products. Pharmacies shall ensure that the production of cannabis end products complies with the provisions of Act No. 1668 and with the provisions of this Order. Texto completo Danés Página web www.retsinformation.dk Referencias - Legislación Implementa Act No. 1668 on a pilot scheme for medicinal cannabis. Legislación | Dinamarca | 2017 Palabra clave: Cultivos prohibidos, Comercio internacional, Envasado/etiquetado, Procesamiento/manipulación, Salud pública Fuente: FAO, FAOLEX